CPT code 85293: Kininogen assay, fitzgerald factor2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Measures high-molecular-weight kininogen, or Fitzgerald factor, during specialized evaluation of an unexplained prolonged activated partial thromboplastin time.
Medicare pays $18.93 for 85293 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$18.93
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 85293 covers
Code 85293 represents a laboratory measurement of high-molecular-weight kininogen, also called Fitzgerald factor, a protein in the contact pathway of coagulation. Clinicians may order it when evaluating an unexplained prolonged activated partial thromboplastin time (aPTT), particularly when more common intrinsic-pathway factor deficiencies do not explain the result. Deficiency can prolong in-vitro clotting tests without the bleeding pattern expected with deficiencies of factors VIII, IX, or XI. Clinical laboratories perform the assay on citrated plasma as part of specialized hemostasis testing.
Report 85293 for the Fitzgerald-factor assay; it is distinct from testing for prekallikrein (Fletcher factor) and other clotting factors. Medicare pays the test through the CLFS only. The 2026 national CLFS amount is $18.93, unchanged since 2020, and applies in every state and locality without an office or facility adjustment. The physician fee schedule excludes this test by statute.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 85293
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 85293. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 85293 with status X (excluded by statute), so the test itself is paid only from the CLFS.
85293 on the lab fee schedule since 2020
85293 · CLFS 2026 Q4 (current)
$18.93
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
85293 compared with similar tests
- 85292Prekallikrein assayFletcher factor measurement$18.93
- Choose 85293 for high-molecular-weight kininogen (Fitzgerald factor); 85292 is for prekallikrein (Fletcher factor).
- 85280Factor XIIHageman factor activity$19.35
- 85293 measures high-molecular-weight kininogen, while 85280 measures factor XII. They are separate assays despite both relating to contact-pathway evaluation.
- 85270Factor XI assayFactor XI (PTA)$17.90
- 85293 is the Fitzgerald-factor assay; 85270 measures factor XI activity. Select the code for the specific factor tested.
85293 billing questions
When would a clinician order the Fitzgerald-factor assay?
It may be ordered during a specialized workup of an unexplained prolonged aPTT when other intrinsic-pathway factor deficiencies do not account for the result.
How is 85293 different from 85292?
85293 measures high-molecular-weight kininogen, or Fitzgerald factor. Code 85292 is for prekallikrein, also known as Fletcher factor.
Is 85293 the same test as a factor XII assay?
No. Code 85293 measures high-molecular-weight kininogen; factor XII testing is reported separately under 85280.
How does Medicare pay for 85293?
Medicare pays the test through the CLFS only. Its national amount applies across localities without an office or facility adjustment.
Is a physician interpretation separately paid under the physician fee schedule?
The physician fee schedule excludes this test by statute; Medicare payment for the test is through the CLFS.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 85293 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist